One-year outcomes of the pivotal clinical trial of a balloon-expandable transcatheter aortic valve implantation in Japanese dialysis patients

Published:August 02, 2021DOI:


      • Surgical aortic valve replacement is generally high risk in dialysis patients.
      • Transcatheter aortic valve replacement in dialysis patients showed good results.
      • This procedure using SAPIEN 3 is safe and effective in dialysis patients.



      Dialysis patients with aortic stenosis are generally considered as being at extreme or high surgical risk. Herein, the first clinical trial was conducted to investigate clinical safety and effectiveness of transcatheter aortic valve replacement (TAVR) using the balloon-expandable transcatheter aortic valve (SAPIEN 3, Edwards Lifesciences, Irvine, CA, USA) in Japanese dialysis patients.


      The clinical trial is a single arm, prospective, open, non-randomized, Japanese multicenter study. The primary purpose of this trial is to evaluate the efficacy and safety of TAVR using SAPIEN 3 in 28 Japanese dialysis patients.


      Mean age was 79.2 years and 67.9% were male (Mean STS score was 14.3%). Transfemoral and transapical approaches were performed in 25 (89.3%) and 3 patients (10.7%), respectively. All bioprostheses were successfully implanted. Median intensive care unit stay and hospital stay after TAVR were 1.4 days and 6.3 days, respectively. In-hospital mortality was 3.6% and freedom from all-cause mortality at 1 year was 89.3%. Disabling stroke and life-threatening bleeding at 1 year was 7.7% and 8.5%, respectively. There was no structural valve deterioration during follow-up. New York Heart Association functional status, six-minute walk test, and EuroQOL visual analogue scale score significantly improved through 1 year compared with baseline.


      TAVR using SAPIEN 3 is safe and effective for the treatment of Japanese dialysis patients with symptomatic severe aortic valve stenosis.

      Graphical abstract


      To read this article in full you will need to make a payment
      Subscribe to Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Mack MJ
        • Leon MB
        • Thourani VH
        • Makkar R
        • Kodali SK
        • Russo M
        • et al.
        Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients.
        N Engl J Med. 2019; 380: 1695-1705
        • Popma JJ
        • Deeb GM
        • Yakubov SJ
        • Mumtaz M
        • Gada H
        • O'Hair D
        • et al.
        Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients.
        N Engl J Med. 2019; 380: 1706-1715
        • Maher ER
        • Young G
        • Smyth-Walsh B
        • Pugh S
        • Curtis JR.
        Aortic and mitral valve calcification in patients with end-stage renal disease.
        Lancet. 1987; 2: 875-877
        • Maeda K
        • Kuratani T
        • Mizote I
        • Shimamura K
        • Ichibori Y
        • Onishi T
        • et al.
        Midterm outcomes of transcatheter aortic valve replacement in dialysis patients with aortic valve stenosis.
        Circ J. 2019; 83: 1600-1606
      1. The ATS committee on proficiency standards for clinical pulmonary function laboratories. ATS statement: guidelines for the six-minute walk test.
        Am J Respir Crit Care Med. 2002; 166: 111-117
        • Yamamura M
        • Mitsuno M
        • Tanaka H
        • Kobayashi Y
        • Ryomoto M
        • Nishi H
        • et al.
        Risk factors for open heart surgery in hemodialysis patients.
        Gen Thorac Cardiovasc Surg. 2009; 57: 235-238
        • Azuma S
        • Higashiue S
        • Kawahira T
        • Matsubayashi K
        • Tonda H
        • Komooka M
        • et al.
        Long-term results following aortic valve replacement for aortic valve stenosis in patients with dialysis-dependent renal failure and risk factors for prognosis.
        Jpn J Cardiovasc Surg. 2013; 42: 274-278
        • Yamauchi T
        • Yamamoto H
        • Miyata H
        • Kobayashi J
        • Masai T
        • Motomura N.
        Surgical aortic valve replacement for aortic stenosis in dialysis patients- analysis of Japan Cardiovascular Surgery Database.
        Circ J. 2020; 84: 1271-1276
        • Kawase Y
        • Taniguchi T
        • Morimoto T
        • Kadota K
        • Iwasaki K
        • Kuwayama A
        • et al.
        Severe aortic stenosis in dialysis patients.
        J Am Heart Assoc. 2017; 6e004961
        • Mentias A
        • Desai MY
        • Saad M
        • Horwitz PA
        • Rossen JD
        • Panaich S
        • et al.
        Management of aortic stenosis in patients with end-stage renal disease on hemodialysis.
        Circ Cardiovasc Interv. 2020; 13e009252
        • Alkhalil A
        • Golbari S
        • Song D
        • Lamba H
        • Fares A
        • Alaiti A
        • et al.
        In-hospital outcomes of transcatheter versus surgical aortic valve replacement in end stage renal disease.
        Catheter Cardiovasc Interv. 2018; 92: 757-765
        • Thourani VH
        • Keeling WB
        • Sarin EL
        • Guyton RA
        • Kilgo PD
        • Dara AB
        • et al.
        Impact of preoperative renal dysfunction on long-term survival for patients undergoing aortic valve replacement.
        Ann Thorac Surg. 2011; 91: 1798-1806
        • Hanafusa N
        • Nakai S
        • Iseki K
        • Tsubakihara Y.
        Japanese Society for Dialysis Therapy renal data registry-a window through which we can view the details of Japanese dialysis population.
        Kidney Int. 2011; 5 (Suppl2015): 15-22
        • Schymik G
        • Bramlage P
        • Herzberger V
        • Bergmann J
        • Conzelmann LO
        • Wurth A
        • et al.
        Impact of dialysis on the prognosis of patients undergoing transcatheter aortic valve implantation.
        Am J Cardiol. 2019; 123: 315-322
        • Szerlip M
        • Zajarias A
        • Vemalapalli S
        • Brennan M
        • Dai D
        • Maniar H
        • et al.
        Transcatheter aortic valve replacement in patients with end-stage renal disease.
        J Am Coll Cardiol. 2019; 73: 2806-2815
        • Afilalo J
        • Lauck S
        • Kim DH
        • Lefevre T
        • Piazza N
        • Lachapelle K
        • et al.
        Frailty in older adults undergoing aortic valve replacement: the FRAILTY-AVR Study.
        J Am Coll Cardiol. 2017; 70: 689-700
        • Shimura T
        • Yamamoto M
        • Kano S
        • Kagase A
        • Kodama A
        • Koyama Y
        • et al.
        Impact of frailty markers on outcomes after transcatheter aortic valve replacement: insights from a Japanese multicenter registry.
        Ann Cardiothorac Surg. 2017; 6: 532-537
        • Miyasaka M
        • Tada N
        • Taguri M
        • Kato S
        • Enta Y
        • Hata M
        • et al.
        Incidence and predictors of prosthesis-patient mismatch after TAVI using SAPIEN 3 in Asian: differences between the newer and older balloon-expandable valve.
        Open Heart. 2021; 8e001531
        • Theron A
        • Pinto J
        • Grisoli D
        • Griffiths K
        • Salaun E
        • Jaussaud N
        • et al.
        Patient-prosthesis mismatch in new generation trans-cathter heart valves: a propensity score analysis.
        Eur Heart J Cardiovasc Imaging. 2018; 19: 225-233
        • Ichibori Y
        • Mizote I
        • Maeda K
        • Onishi T
        • Ohtani T
        • Yamaguchi O
        • et al.
        Clinical outcomes and bioprosthetic valve function after transcatheter aortic valve implantation under dual antiplatelet therapy vs. aspirin alone.
        Circ J. 2017; 81: 397-404
        • Stabile E
        • Pucciarelli A
        • Cota L
        • Sorropago G
        • Tesorio T
        • Salemme L
        • et al.
        SAT-TAVI (single antiplatelet therapy for TAVI) study: a pilot randomized study comparing double to single antiplatelet therapy for transcatheter aortic valve implantation.
        Int J Cardiol. 2014; 174: 624-627
        • Overtchouk P
        • Guedeney P
        • Rouanet S
        • Verhoye JP
        • Lefevre T
        • Van Belle E
        • et al.
        Long-term mortality and early valve dysfunction according to anticoagulation use: The FRANCE-TAVI registry.
        J Am Coll Cardiol. 2019; 73: 13-21
        • Brinkman WT
        • Williams WH
        • Guyton RA
        • Jones EL
        • Craver JM.
        Valve replacement in patients on chronic renal dialysis: implications for valve prosthesis selection.
        Ann Thorac Surg. 2002; 74: 37-42
        • Lucke JC
        • Samy RN
        • Atkins BZ
        • Silvestry SC
        • Douglas Jr., JM
        • Schwab SJ
        • et al.
        Results of valve replacement with mechanical and biological prostheses in chronic renal dialysis patients.
        Ann Thorac Surg. 1997; 64: 129-132
        • Chan KE
        • Lazarus JM
        • Thadhani R
        • Hakim RM.
        Warfarin use associates with increased risk for stroke in hemodialysis patients with atrial fibrillation.
        J Am Soc Nephrol. 2009; 20: 2223-2233
        • Hirakata H
        • Nitta K
        • Inaba M
        • Shoji T
        • Fujii H
        • Kobayashi S
        • et al.
        Japanese Society for Dialysis Therapy guidelines for management of cardiovascular diseases in patients on chronic hemodialysis.
        Ther Apher Dial. 2012; 16: 387-435
        • Tabata N
        • Sinning JM
        • Kaikita K
        • Tsujita K
        • Nickenig G
        • Werner N.
        Current status and future perspective of structural heart disease intervention.
        J Cardiol. 2019; 74: 1-12
        • Boning A
        • Boedeker RH
        • Rosendahl UP
        • Niemann B
        • Haberer S
        • Roth P
        • et al.
        Long-term results of mechanical and biological heart valves in dialysis and non-dialysis patients.
        Thorac Cardiovasc Surg. 2011; 59: 454-459